Factory Price Glp-1(7-37) Acetate Provider - Octreotide Acetate – JYMed
Factory Price Glp-1(7-37) Acetate Provider - Octreotide Acetate – JYMed Detail:
Keywords
- Octreotide Acetate
- most affordable price
- CAS# 83150-76-9
Quick Details
- ProName: Octreotide acetate
- CasNo: 83150-76-9
- Molecular Formula: C49H66N10O10S2
- Appearance: white powder
- Application: Fields of Application: Acromegaly Ca…
- DeliveryTime: prompt shipment
- PackAge: according to customer’s requirements
- Port: Shenzhen
- ProductionCapacity: 5 Kilogram/Month
- Purity: 98%
- Storage: 2~8℃. protected from light
- Transportation: by air
- LimitNum: 1 Gram
Superiority
professional peptide manufacturer in china.
high quality with gmp grade
large scale with competitive price
our products include: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.
Molecular Formula:
C49H66N10O10S2
Relative Molecular Mass:
1019.26 g/mol
CAS-Number:
83150-76-9 (net), 79517-01-4 (acetate)
Long-term Storage:
-20 ± 5°C
Synonym:
SMS 201-995
Sequence:
H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol acetate salt (Disulfide bond)
Fields of Application:
Acromegaly Carcinoid syndrome VIPomas
Active Substance:
Octreotide Acetate is a longer acting synthetic octapeptide analog of naturally occurring somatostatin. Octreotide Acetate inhibits the secretion of gastro-entero-pancreatic peptide hormones and the release of growth hormone. Octreotide reduces gastrointestinal motility and inhibits contraction of the
gall bladder.
Company Profile:
company name:Shenzhen JYMed Technology Co.,Ltd.
Year Established:2009
Capital: 89.5 Million RMB
Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin
Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,…..
We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.JYM has successfully submitted a lot
of ANDA peptide APIs and formulated products with CFDA and have over fourty patents approved.
Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.
Product detail pictures:
Related Product Guide:
Debiopharm Group Regains the Commercial Rights to Trelstar® (Triptorelin pamoate) and Looks for New Partners in North America | Trelstar(Triptorelin Pamoate)
Pretreatment with β-Boswellic Acid Improves Blood Stasis Induced Endothelial Dysfunction: Role of eNOS Activation | Synthetic Angiotensin Ii Gmp Provider From China
The company upholds the philosophy of "Be No.1 in quality, be rooted on credit and trustworthiness for growth", will continue to serve old and new customers from home and overseas whole-heatedly for Factory Price Glp-1(7-37) Acetate Provider - Octreotide Acetate – JYMed, The product will supply to all over the world, such as: Oman, Ghana, Manila, Each customer's satisfactory is our goal. We are looking for long-term cooperation with each customer. To meet this, we keep up our quality and provide extraordinary customer service. Welcome to our company, we are expecting to cooperate with you.
By Astrid from British - 2015.05.13 17:00
In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
By Teresa from Mexico - 2015.05.13 17:00